Audit
audit · board committee · Current
- Chair
- Thomas Ricks
Skip to recordView board details →
Explore all Claims →
Alpha Governance Record
- Record version
- public-1
- Last updated
- Oct 6, 2026
- Completeness
- 41%
- Record Quality
- 83 / 100
- Evidence coverage
- 4
- Verification status
- Source reported
- Directors
- 7
- Committees
- 7
- Governance events
- 12
Alpha ID: alpha:company:59b43374-ca31-4533-861d-e1452e3887bfSchema: alpha-governance-record-v2Ontology: alpha-governance-ontology-v123 published Claims4 sources
Governance at a glance
Each value is read from the published Record. “Not published” means no evidence-backed Claim exists in this Record yet; it is never a finding about the company.
- Board size
- 5Published current seats
- Independence
- 4 of 5 determined80%
- CEO and chair
- Not published
- Lead independent director
- Not published
- Key committees
- 7 of 7 published
- Ownership concentration
- Not published
- Auditor
- Not published
- Recent governance changes
- 12 derived eventsGC CHANGED
- Shareholder dissent
- Not published
- AI oversight
- Not published
- Cyber oversight
- Not published
- Material legal matters
- Not published
- Alpha Verify status
- Source reportedIdentity: unclaimed
- Record Quality
- 83 / 100Describes Alpha's Record, not the company
Governance record
Record overview
Explore Faeth Therapeutics, Inc.'s published governance Claims, committee structure, and linked sources. Each item reflects the scope and dates of its source.
About this record →- Company
- Faeth Therapeutics, Inc.
- Published Claims
- 23
- Evidence records
- 4
- Record version
- public-1
Record highlights
Only published Claims appear in these highlights.
Shareholders →
No source-linked Claim published yet.
Compensation →
No source-linked Claim published yet.
Legal →
No source-linked Claim published yet.
Committee overview
Committee summaries link to the published Claim and its source evidence.
| Committee | Disclosed mandate or composition |
|---|---|
| Audit | Chair: Thomas Ricks · 3 listed members |
| Compensation | Chair: Bob Holmen · 4 listed members |
| Nominating and Governance | Chair: William Ringo · 2 listed members |
Key governance topics
Counts describe published Claims in this record.
Key Claims
- Leadership RoleBob Holmen: Director, Audit; Compensation · ChairSensei Biotherapeutics, Inc. DEF 14A 2025-04-11
- Leadership RoleJames Peyer: Director, Compensation; Nominating and GovernanceSensei Biotherapeutics, Inc. DEF 14A 2025-04-11
- Leadership RoleJohn Celebi: DirectorSensei Biotherapeutics, Inc. DEF 14A 2025-04-11
- Leadership RoleKristian Humer: DirectorSensei Biotherapeutics, Inc. DEF 14A 2025-04-11
What changed
- GC CHANGED: Christopher W. Gerry executive of Faeth Therapeutics, Inc., effective 2026-04-27.Apr 27, 2026
- DIRECTOR APPOINTED: Kristian Humer seat on Faeth Therapeutics, Inc., effective 2021-01-01.Jan 1, 2021
- DIRECTOR APPOINTED: James Peyer seat on Faeth Therapeutics, Inc., effective 2020-01-01.Jan 1, 2020
Board
Published
Published board seats, independence determinations, tenure and committee roles.
- Published seats
- 5Alpha-calculated metric · Count of published current board seats in this Record. Roster completeness is not asserted.
- Independent share
- 80%Alpha-calculated metric · Board independence determinations are source facts; the share is computed only over directors with a published determination.
- Average tenure
- 8.6 years (5 dated)Alpha-calculated metric · Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.
- Committee load
- 3 per directorAlpha-calculated metric · Average published committee memberships per current director with at least one published membership.
| Director | Role | Independent | Since | Committees | Status | Claim |
|---|---|---|---|---|---|---|
| Bob Holmen | Director | YesBoard determination | 2017-01-01 | AuditAudit; Compensation · ChairCompensation (Chair) | Current | Evidence |
| James Peyer | Director | YesBoard determination | 2020-01-01 | CompensationCompensation; Nominating and GovernanceNominating and Governance | Current | Evidence |
| John Celebi | Director | NoBoard determination | 2018-01-01 | Not published | Current | Evidence |
| Kristian Humer | Director | YesBoard determination | 2021-01-01 | Not published | Current | Evidence |
| Thomas Ricks | Director | YesBoard determination | 2015-01-01 | Audit (Chair)Audit · Chair; CompensationCompensation | Current | Evidence |
| Kristian Humer | Director (committee appointment) | Not published | Not published | Audit | Status not published | Evidence |
| William Ringo | Director | YesBoard determination | Not published | CompensationCompensation; Nominating and Governance · ChairNominating and Governance (Chair) | Status not published | Evidence |
Skills matrix
Cells show published skill Claims. A blank cell means no Claim is published, not that the director lacks the skill.
| Director | Financial | AI | Cyber | Regulatory | International | Public company | Technology |
|---|---|---|---|---|---|---|---|
| Bob Holmen | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| James Peyer | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| John Celebi | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Kristian Humer | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Thomas Ricks | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Kristian Humer | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| William Ringo | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
No director skill Claims are published in this Record yet.
Not published in this Record: chair, lead independent director, board type, median tenure, average age, refreshment rate, gender diversity, geographic diversity, succession risk, overboarding, board interlocks, attendance.
Published Claims in this section (6)
Committees
Published
Committees are governed objects with temporal memberships, chairs and mandates.
| Director | Audit | Audit · Chair; Compensation | Audit; Compensation · Chair | Compensation | Compensation; Nominating and Governance | Compensation; Nominating and Governance · Chair | Nominating and Governance |
|---|---|---|---|---|---|---|---|
| Thomas Ricks | Chair | Member | Not published | Member | Not published | Not published | Not published |
| Bob Holmen | Member | Not published | Member | Chair | Not published | Not published | Not published |
| Kristian Humer | Member | Not published | Not published | Not published | Not published | Not published | Not published |
| James Peyer | Not published | Not published | Not published | Member | Member | Not published | Member |
| William Ringo | Not published | Not published | Not published | Member | Not published | Member · Status not published | Chair |
Audit · Chair; Compensation
audit · board committee · Current
- Chair
- Not published
- Members
- Thomas Ricks · Evidencemember · since 2015-01-01
Audit; Compensation · Chair
audit · board committee · Current
- Chair
- Not published
- Members
- Bob Holmen · Evidencemember · since 2017-01-01
Compensation
compensation · board committee · Current
- Chair
- Bob Holmen
Compensation; Nominating and Governance
compensation · board committee · Current
- Chair
- Not published
- Members
- James Peyer · Evidencemember · since 2020-01-01
Compensation; Nominating and Governance · Chair
compensation · board committee · Status not published
- Chair
- Not published
- Members
- William Ringo · Evidencemember
Nominating and Governance
nominating governance · board committee · Current
- Chair
- William Ringo
Published Claims in this section (12)
Leadership
Published
Executive roles as published; role codes are title normalizations, not inferences about authority.
| Executive | Title | Role | Start | Status | Board | Claim |
|---|---|---|---|---|---|---|
| Christopher W. Gerry | President, General Counsel and Secretary | GC | 2026-04-27 | Current | Not published | Evidence |
- CEO
- Not published
- CFO
- Not published
- GC
- Christopher W. Gerry
- CORPORATE_SECRETARY
- Not published
- COO
- Not published
- CHRO
- Not published
- CIO
- Not published
- CTO
- Not published
- CISO
- Not published
- CAIO
- Not published
- CRO
- Not published
Published Claims in this section (1)
Ownership
Not reviewed
Holders, voting power and activism as disclosed. Influence is never inferred from ownership alone.
Activist positions
No activist positions are published in this Record.
Ownership disclosures
No ownership disclosures are published in this Record.
Ownership coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageFinancials
Not reviewed
Governance-relevant financial context with period, unit and source attached to each observation.
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageOther published Claims in this section (1)
Governance
Not reviewed
Governing documents, provisions and shareholder meeting records as versioned policy objects.
Provisions
No charter or bylaw provisions are published in this Record.
Shareholder meetings and votes
No shareholder meeting or vote records are published in this Record.
Governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageRisk
Not reviewed
Risk ownership, audit and assurance, and cyber oversight. Company assertions, independent assurance and Alpha verification stay distinct.
No risk disclosures are published in this Record yet.
Governed risk taxonomy
strategic · financial · operational · legal · regulatory · cyber · privacy · ai · model · agentic · supply_chain · geopolitical · climate · human_capital · reputation · third_party · concentration
Audit and assurance
- External auditor
- Not published
- Auditor tenure
- Not published
- Engagement partner
- Not published
- Alpha verification
- source reported Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.
Material weaknesses and restatements
No material weakness or restatement is published in this Record. This is not a clean-controls conclusion.
Independent assurance
No independent assurance report is published in this Record.
Company assertions
No company assurance assertions are published in this Record.
Cybersecurity and data governance
- Executive owner
- Not published
- Board oversight
- Not published
Cyber and privacy incidents
No cyber or privacy incident is published in this Record. Absence of a disclosure is not absence of an incident.
No further cyber or data governance disclosures are published.
Agent governance
Restricted Agent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
transaction_schema_version=2026-08-29 authority_object=AuthorityGrant pre_action_decision=TrustCheck action_record=GovernanceReceipt plane=private_enterprise_overlay
Risk coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI
Not reviewed
Board and executive oversight of AI, AI policies, incidents and regulation exposure.
- Executive AI owner
- Not published
- Board or committee AI oversight
- Not published
- Responsible AI committee
- Not published
- AI governance framework
- Not published
- Model inventory
- Restricted Private enterprise overlay
AI incidents
No AI incident is published in this Record. Absence of a disclosure is not absence of an incident.
External AI assurance
No external AI assurance is published in this Record.
AI regulation exposure
No AI regulation exposure disclosure is published in this Record.
Other AI governance disclosures
No further AI governance disclosures are published.
AI coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Not reviewed
Litigation, regulatory investigations and enforcement as first-class legal matters.
Legal developments
No legal developments are published in this Record.
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Not reviewed
Executive and director compensation disclosures and metrics.
No compensation disclosures are published in this Record.
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageGovernance events
Published
Events are derived from dated changes in governed relationships and from Registry record supersession. Nothing here is typed by hand.
- 2026-04-27GC CHANGEDChristopher W. Gerry executive of Faeth Therapeutics, Inc., effective 2026-04-27.Temporal change
- 2021-01-01DIRECTOR APPOINTEDKristian Humer seat on Faeth Therapeutics, Inc., effective 2021-01-01.Temporal change
- 2020-01-01DIRECTOR APPOINTEDJames Peyer seat on Faeth Therapeutics, Inc., effective 2020-01-01.Temporal change
- 2020-01-01COMMITTEE CREATEDCompensation; Nominating and Governance committee of Faeth Therapeutics, Inc., effective 2020-01-01.Temporal change
- 2020-01-01COMMITTEE MEMBER ADDEDJames Peyer member of Compensation; Nominating and Governance, effective 2020-01-01.Temporal change
- 2018-01-01DIRECTOR APPOINTEDJohn Celebi seat on Faeth Therapeutics, Inc., effective 2018-01-01.Temporal change
- 2017-01-01DIRECTOR APPOINTEDBob Holmen seat on Faeth Therapeutics, Inc., effective 2017-01-01.Temporal change
- 2017-01-01COMMITTEE CREATEDAudit; Compensation · Chair committee of Faeth Therapeutics, Inc., effective 2017-01-01.Temporal change
- 2017-01-01COMMITTEE MEMBER ADDEDBob Holmen member of Audit; Compensation · Chair, effective 2017-01-01.Temporal change
- 2015-01-01DIRECTOR APPOINTEDThomas Ricks seat on Faeth Therapeutics, Inc., effective 2015-01-01.Temporal change
- 2015-01-01COMMITTEE CREATEDAudit · Chair; Compensation committee of Faeth Therapeutics, Inc., effective 2015-01-01.Temporal change
- 2015-01-01COMMITTEE MEMBER ADDEDThomas Ricks member of Audit · Chair; Compensation, effective 2015-01-01.Temporal change
Evidence, history and coverage
Additional published Claims
Published evidence records
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 6, 2026
Supports 4 claims
- Legal Name: Faeth Therapeutics, Inc. · Claim reviewed: Oct 6, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 6, 2026
- Published Fact: US · Claim reviewed: Oct 6, 2026
- Security Listing: FTH (NASDAQ) · Claim reviewed: Oct 6, 2026
Sensei Biotherapeutics, Inc. DEF 14A 2025-04-11
sec proxy · Source published: Apr 11, 2025 · Retrieved: Apr 28, 2026
Supports 6 claims
- Leadership Role: Bob Holmen: Director, Audit; Compensation · Chair · Claim reviewed: Oct 6, 2026
- Leadership Role: James Peyer: Director, Compensation; Nominating and Governance · Claim reviewed: Oct 6, 2026
- Leadership Role: John Celebi: Director · Claim reviewed: Oct 6, 2026
- Leadership Role: Kristian Humer: Director · Claim reviewed: Oct 6, 2026
- Leadership Role: Thomas Ricks: Director, Audit · Chair; Compensation · Claim reviewed: Oct 6, 2026
- Leadership Role: William Ringo: Director, Compensation; Nominating and Governance · Chair · Claim reviewed: Oct 6, 2026
SNSE DEF 14A executive officers
sec filing · Source published: Apr 27, 2026 · Retrieved: May 16, 2026
Supports 1 claim
- Leadership Role: Christopher W. Gerry: President, General Counsel and Secretary · Claim reviewed: Oct 6, 2026
Audit
board seats · Source published: Date unavailable · Retrieved: Date unavailable
Supports 12 claims
- Committee Record: Audit: Chair Thomas Ricks; Members Thomas Ricks (Chair); Bob Holmen; Kristian Humer · Claim reviewed: Oct 6, 2026
- Committee Appointment: Thomas Ricks: chair, Audit · Claim reviewed: Oct 6, 2026
- Committee Appointment: Bob Holmen: member, Audit · Claim reviewed: Oct 6, 2026
- Committee Appointment: Kristian Humer: member, Audit · Claim reviewed: Oct 6, 2026
- Committee Record: Compensation: Chair Bob Holmen; Members Bob Holmen (Chair); James Peyer; Thomas Ricks; William Ringo · Claim reviewed: Oct 6, 2026
- Committee Appointment: Bob Holmen: chair, Compensation · Claim reviewed: Oct 6, 2026
- Committee Appointment: James Peyer: member, Compensation · Claim reviewed: Oct 6, 2026
- Committee Appointment: Thomas Ricks: member, Compensation · Claim reviewed: Oct 6, 2026
- Committee Appointment: William Ringo: member, Compensation · Claim reviewed: Oct 6, 2026
- Committee Record: Nominating and Governance: Chair William Ringo; Members William Ringo (Chair); James Peyer · Claim reviewed: Oct 6, 2026
- Committee Appointment: William Ringo: chair, Nominating and Governance · Claim reviewed: Oct 6, 2026
- Committee Appointment: James Peyer: member, Nominating and Governance · Claim reviewed: Oct 6, 2026
- 2026-04-27GC CHANGEDChristopher W. Gerry executive of Faeth Therapeutics, Inc., effective 2026-04-27.Temporal change
- 2021-01-01DIRECTOR APPOINTEDKristian Humer seat on Faeth Therapeutics, Inc., effective 2021-01-01.Temporal change
- 2020-01-01DIRECTOR APPOINTEDJames Peyer seat on Faeth Therapeutics, Inc., effective 2020-01-01.Temporal change
- 2020-01-01COMMITTEE CREATEDCompensation; Nominating and Governance committee of Faeth Therapeutics, Inc., effective 2020-01-01.Temporal change
- 2020-01-01COMMITTEE MEMBER ADDEDJames Peyer member of Compensation; Nominating and Governance, effective 2020-01-01.Temporal change
- 2018-01-01DIRECTOR APPOINTEDJohn Celebi seat on Faeth Therapeutics, Inc., effective 2018-01-01.Temporal change
- 2017-01-01DIRECTOR APPOINTEDBob Holmen seat on Faeth Therapeutics, Inc., effective 2017-01-01.Temporal change
- 2017-01-01COMMITTEE CREATEDAudit; Compensation · Chair committee of Faeth Therapeutics, Inc., effective 2017-01-01.Temporal change
- 2017-01-01COMMITTEE MEMBER ADDEDBob Holmen member of Audit; Compensation · Chair, effective 2017-01-01.Temporal change
- 2015-01-01DIRECTOR APPOINTEDThomas Ricks seat on Faeth Therapeutics, Inc., effective 2015-01-01.Temporal change
- 2015-01-01COMMITTEE CREATEDAudit · Chair; Compensation committee of Faeth Therapeutics, Inc., effective 2015-01-01.Temporal change
- 2015-01-01COMMITTEE MEMBER ADDEDThomas Ricks member of Audit · Chair; Compensation, effective 2015-01-01.Temporal change
Identity
unclaimed
Evidence
source reported
Evaluation
not evaluated
Monitoring
Unknown
Authority
Unknown
Freshness
current
Section coverage
Completeness 41% of expected sections for a public company. States describe Alpha's Record, not the company. Missing expected sections: corporate_structure, ownership, financials, compensation, governance, shareholder_governance, audit, legal, risk, cyber, ai_governance, markets_external.
- Identity
- Published
- Corporate structure
- Not reviewed
- Board
- Published
- Committees
- Published
- Leadership
- Published
- Ownership and shareholders
- Not reviewed
- Financials
- Not reviewed
- Capital structure
- Published
- Compensation
- Not reviewed
- Governance
- Not reviewed
- Shareholder governance
- Not reviewed
- Audit and assurance
- Not reviewed
- Legal and regulatory
- Not reviewed
- Risk
- Not reviewed
- Cybersecurity and data governance
- Not reviewed
- AI governance
- Not reviewed
- Agent governance
- Restricted
- Markets and external ecosystem
- Not reviewed
- Governance events
- Published
- Relationships
- Published
- Assessments and Evals
- Published
- Evidence
- Published